All In Biotech

Drug Trial Radar · NCT05202327

PDC-1421 Treatment in Adult Patients With ADHD

A Phase II Tolerability and Efficacy Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD), Part II

Last checked: Nov 20, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

99

Actual

Start

Apr 7, 2022

Primary completion

Dec 6, 2023

Study completion Apr 8, 2024

Sponsor

Lead sponsor
BioLite, Inc.Industry
Sponsor type
Industry
Collaborators
ABVC BioPharma, Inc.
First posted
Jan 21, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Part II is a double-blind, randomized, parallel-group, placebo-controlled study. The primary objective of this trial is to determine the effective doses and treatment period of PDC-1421 Capsule in subjects with ADHD. The secondary objective is to evaluate the safety of PDC-1421 Capsule in subjects receiving PDC-1421 at various dose levels.

Conditions

  • Attention-Deficit Hyperactivity Disorder (ADHD)

Interventions

  • PDC-1421 CapsuleDrug

    PDC-1421 Capsule is a botanical investigational new drug containing the extract of Radix Polygalae (Polygala tenuifolia Willd.) as the active ingredient.

  • PlaceboDrug

    The placebo contained corn starch.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Improvement ≥ 40% in ADHD-RS-IV From Baseline up to 8 Weeks TreatmentTime frame: 8 weeks

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • University of California, San Francisco

    San Francisco, California

  • Kaohsiung Chang Gung Memorial Hospital

    Kaohsiung City, Taiwan

  • National Taiwan University Hospital

    Taipei, Taiwan

  • Cheng Hsin General Hospital

    Taipei, Taiwan

  • Taipei veterans General Hospital

    Taipei, Taiwan

  • Linkou chang Gung Memorial Hospital

    Taoyuan, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.